COVID-19 information↵ Skip to main content↵ Go to site menu↵ Jump to page footer↵
UTMB News The University of Texas Medical Branch
Explore UTMB
  • Health Care
  • Academics
  • Research
  • All UTMB
  • Support
  • Search
UTMB Health
  • UTMB News
  • Categories
    • News Releases
    • UTMB In The News
    • UTMB Research
    • Awards & Accolades
    • UTMB Experts
  • For the Media
    • Press Releases
    • Contact Us
  • Archives
Menu
  • COVID-19 Spreading through Hispanic and Latin populations at higher rates

    July 9, 2020 • 12:57 p.m.

    Local online news source i45NOW interviews UTMB’s Shannon Guillot-Wright, director of health policy research for the Center for Violence Prevention, about the increased number of COVID-19 infections within the local Hispanic population. KRGV Weslaco also interviewed Guillot-Wright.

    Read more
  • Image of mosquito

    UTMB leading new international center for anticipating and countering mosquito-borne diseases

    July 7, 2020 • 9:31 a.m.

    Researchers from The University of Texas Medical Branch at Galveston have received more than $7.7 million from the National Institute of Allergy & Infectious Diseases to spearhead a Center to identify, track and counter mosquito-borne diseases.

    Read more
  • IBM Watson Health Graphic

    UTMB earns spot on best hospitals list

    July 3, 2020 • 2:37 p.m.

    Galveston, Texas – The University of Texas Medical Branch at Galveston has been named to the IBM Watson Health 100 Top Hospitals list. Specifically, UTMB ranked in the top 15 nationwide among major teaching hospitals on the list. IBM Watson Health recognizes hospitals of all sizes in five different categories – major teaching hospitals, large community hospitals, medium community hospitals and smaller community hospitals.

    Read more
  • covie-19 research graphic

    Estrogen and testosterone therapies may decrease severity of COVID-19

    June 9, 2020 • 9:00 a.m.

    Researchers from The University of Texas Medical Branch at Galveston explored the effects of estrogen and testosterone and their possible therapeutic effects in treating older patients with COVID-19. The findings are now available in Mayo Clinic Proceedings.

    Read more
  • Beat covid image

    UTMB part of NIH-funded study of how COVID-19 pandemic may impact pregnancy outcomes

    June 1, 2020 • 10:46 a.m.

    A team of researchers from The University of Texas Medical Branch at Galveston, led by Dr. George Saade, are active partners in the National Institutes of Health’s newly launched study to learn more about the impact of the COVID-19 pandemic on pregnancy and post-partum care.

    Read more
  • Vaccine Smarts-Polio vaccine could help us knock out COVID-19

    May 27, 2020 • 3:41 p.m.

    A large number of vaccine clinical trials are underway in the battle against COVID-19. According to Megan Berman and Richard Rupp there is a study testing if oral polio vaccine may be able to prevent SARS-CoV-2 infections.

    Read more
  • Finding a cure: Texas research lab confirms drug blocks coronavirus in human cells

    May 19, 2020 • 10:08 a.m.

    UTMB’s Galveston National Laboratory was one of three labs to confirm a therapeutics company’s drugs were able to neutralize the pandemic coronavirus. “Our lab tested a panel of antibodies against a real SARS-CoV-2 in biocontainment. We were pleased to see very good neutralizing activity for some antibodies,” said UTMB’s Alex Bukreyev.

    Read more
  • Single-use masks can be disinfected, reused according to latest UTMB research

    May 11, 2020 • 10:58 a.m.

    Personal protective equipment, and in particular masks, have been a topic of much concern for front-line health care workers and first responders dealing with spread of the new coronavirus. The global spread of the disease has strained supplies and disrupted supply chain, making the needed masks harder to come by.

    Read more
  • Sealy & Smith Smith Foundation Gives $3.35M to UTMB for COVID-19 Research

    April 29, 2020 • 11:47 a.m.

    The Sealy & Smith Foundation of Galveston has awarded a $3.35 million gift to the University of Texas Medical Branch to support research focused on a portfolio of studies to develop medical countermeasures to fight the COVID-19 virus.

    Read more
  • Marburg virus graphic

    Researchers uncover mechanisms of protective antibody response during deadly Marburg virus infection

    April 21, 2020 • 10:37 a.m.

    A detailed study of the monoclonal antibodies from a person who survived a Marburg infection led researchers to identify novel mechanisms that contribute protection against the disease, according to the latest findings of a collaborative team led by The University of Texas Medical Branch at Galveston and Vanderbilt University Medical Center. The findings are now available in Cell Host & Microbe.

    Read more
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10

Categories

  • Alumni News
  • Awards & Accolades
  • Education
  • Faculty/Staff News
  • Health Care
  • In The News
  • News Releases
  • Top News
  • UTMB Research
Contact Media Team
UTMB Experts
Covid News
Skip Menu
  • UTMB News
  • Categories
    • News Releases
    • UTMB In The News
    • UTMB Research
    • Awards & Accolades
    • UTMB Experts
  • For the Media
    • Press Releases
    • Contact Us
  • Archives
Navigate
Explore UTMB
  • Health Care
  • Academics
  • Research
  • All UTMB
  • Support
UTMB Health is committed to diversity, equity and inclusion.
Back to top
UTMB.eduUTMBHealth.comMaps & DirectionsPrivacy Policy & Required Links
© The University of Texas Medical Branch at Galveston   Member, Texas Medical Center®
UTMB Web:  WWW Login | Intranet Login
UTMB Health